3-158732270-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_206963.2(RARRES1):c.146C>T(p.Pro49Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,210,326 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_206963.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RARRES1 | NM_206963.2 | c.146C>T | p.Pro49Leu | missense_variant | 1/6 | ENST00000237696.10 | NP_996846.1 | |
RARRES1 | NM_002888.4 | c.146C>T | p.Pro49Leu | missense_variant | 1/4 | NP_002879.2 | ||
RARRES1 | XM_005247686.6 | c.146C>T | p.Pro49Leu | missense_variant | 1/6 | XP_005247743.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RARRES1 | ENST00000237696.10 | c.146C>T | p.Pro49Leu | missense_variant | 1/6 | 1 | NM_206963.2 | ENSP00000237696 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.0000149 AC: 18AN: 1210326Hom.: 0 Cov.: 38 AF XY: 0.00000848 AC XY: 5AN XY: 589428
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2023 | The c.146C>T (p.P49L) alteration is located in exon 1 (coding exon 1) of the RARRES1 gene. This alteration results from a C to T substitution at nucleotide position 146, causing the proline (P) at amino acid position 49 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at